Insights Into Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Teva- Pharmaceutical Industries Ltd. ADR is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Teva- Pharmaceutical Industries Ltd. ADR is $20.35B. A total of 3.1 million shares were traded on the day, compared to an average of 7.79M shares.

In the most recent transaction, Daniell Richard sold 98,943 shares of TEVA for 17.30 per share on Aug 12 ’24. After the transaction, the Exec. VP, European Commercial now owns 0 company shares. In a previous transaction on Aug 09 ’24, Grant Angus sold 4,065 shares at 17.28 per share. TEVA shares that EVP, Business Development owns now total 8,848.

Among the insiders who sold shares, Hughes Eric A disposed of 45,060 shares on Aug 09 ’24 at a per-share price of $17.38. This resulted in the See “Remarks” holding 0 shares of TEVA after the transaction. In another insider transaction, Daniell Richard bought 98,943 shares at $17.30 per share on Aug 12 ’24.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, TEVA has a high of $19.08 and a low of $8.06.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. TEVA’s latest balance sheet shows that the firm has $2.17B in Cash & Short Term Investments as of fiscal 2021. There were $23.46B in debt and $11.03B in liabilities at the time. Its Book Value Per Share was $5.61, while its Total Shareholder’s Equity was $11.24B.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TEVA is Buy with a score of 4.75.

Most Popular

Related Posts